Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1095631

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
COC(=O)[C@@H]1Cc2c([nH]c3ccccc23)[C@H](c2ccccc2Br)N1

Basic Information

ChEMBL ID CHEMBL1095631
Phase Preclinical
Structure Type MOL
InChI Key QXOOUBWXLCUYFT-IRXDYDNUSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names

Molecular Properties

385.3
MW (Da)
3.71
ALogP
3
HBA
2
HBD
54.1
PSA (Ų)
0.66
QED
0
Ro5 Violations
2
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

Natural Product First in Class Prodrug

Extended Properties

Molecular Formula C19H17BrN2O2
MW 385.26
Aromatic Rings 3
Heavy Atoms 24
NP-Likeness 0.13

Activity Summary

IC50 1 meas. best 4.58

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
HT-29
CHEMBL384
IC50 4.58 4.58 26000.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
HT-29 IC50 = 26000.0 nM 4.58 Growth inhibition of human HT-29 cells after 72 hrs by cell titer glo assay 20206015

Literature References

PubMed DOI Target Context # Activities
20206015 10.1016/j.ejmech.2009.10.046 cGMP-specific 3',5'-cyclic phosphodiesterase 2
20206015 10.1016/j.ejmech.2009.10.046 HT-29 2

Data from ChEMBL 36 via Core Engine